Trenaman Logan, Harrison Mark, Hoch Jeffrey S
Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA 98195, United States.
Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Health Aff Sch. 2023 Dec 12;2(1):qxad085. doi: 10.1093/haschl/qxad085. eCollection 2024 Jan.
Hospital quality ratings are widely available to help Medicare beneficiaries make an informed choice about where to receive care. However, how beneficiaries' trade-off between different quality domains (clinical outcomes, patient experience, safety, efficiency) and other considerations (out-of-pocket cost, travel distance) is not well understood. We sought to study how beneficiaries make trade-offs when choosing a hypothetical hospital. We administered an online survey that included a discrete choice experiment to a nationally representative sample of 1025 Medicare beneficiaries. On average, beneficiaries were willing to pay $1698 more for a hospital with a 1-star higher rating on clinical outcomes. This was over twice the value of the patient experience ($691) and safety ($615) domains and nearly 8 times the value of the efficiency domain ($218). We also found that the value of a 1-star improvement depends not only on the quality domain but also the baseline level of performance of the hospital. Generally, it is more valuable for low-performing hospitals to achieve average performance than for average hospitals to achieve excellence.
医院质量评级广泛可得,以帮助医疗保险受益人就是否在何处接受治疗做出明智选择。然而,受益人如何在不同质量领域(临床结果、患者体验、安全性、效率)之间进行权衡,以及与其他因素(自付费用、旅行距离)的权衡关系,目前尚不清楚。我们试图研究受益人在选择一家假设的医院时是如何进行权衡的。我们对1025名医疗保险受益人的全国代表性样本进行了一项在线调查,其中包括一个离散选择实验。平均而言,受益人愿意为临床结果评级高一级的医院多支付1698美元。这是患者体验领域(691美元)和安全领域(615美元)价值的两倍多,几乎是效率领域(218美元)价值的8倍。我们还发现,提高一级评级的价值不仅取决于质量领域,还取决于医院的基线绩效水平。一般来说,绩效不佳的医院达到平均水平比平均水平的医院追求卓越更有价值。